Pre-seed raise of £500k
First £250k SEIS eligible for UK investors
We are seeking to raise a minimum of £500k pre-seed to build and launch ScreenND™, the world's first NICE-aligned, parent-led digital screening platform for ADHD and Autism. We welcome investment from the UK and internationally.
The Challenge
Waiting lists for ADHD and Autism assessment now stretch into years. Families are left without answers, schools are under pressure, and clinicians lack early, accurate tools.
This is a critical moment. Without funding, families remain stuck in a broken system. With investment, ScreenND™ can deliver the first scalable, NICE-aligned solution to bridge this gap.
Our Plan
Your investment will allow us to:
Complete our MVP and deliver age-routed, multi-informant screening
Run pilot programmes with schools, families, and clinicians
Validate clinically with real-world data
Build traction and partnerships with a pathway to NHS, local authority, and international adoption
Prepare for our next raise to scale the platform further
The Raise
Target: £500k minimum pre-seed raise
Eligibility: open to UK and international investors
UK investors benefit from SEIS: first £250k qualifies for 50% tax relief
Use of funds: investment will be allocated across MVP development (core platform build and hosting), clinical validation and advisory, pilot programmes with early partners, licensing of validated screening tools, targeted marketing and outreach, operational overheads, and contingency.
Runway: 18 months
Why Now
Demand for early screening has never been higher
NICE guidance creates an urgent need for accurate, evidence-based tools
Families, schools, and clinicians are actively searching for solutions
ScreenND™ is ready to build. Investment is the key that unlocks delivery.
Join us in transforming children's healthcare.
Complete the form below to register your interest or request our full investor deck.